- Termination of Registration of a Class of Security under Section 12(g) (15-12G)
24 12월 2009 - 8:11PM
Edgar (US Regulatory)
|
OMB APPROVAL
|
OMB Number: 3235-0167
Expires: November 30,
2010
Estimated average burden
hours per response . . . . . 1.50
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
|
|
|
Commission File Number:
|
|
0-18311
|
Neurogen Corporation
(Exact name of registrant as specified in its charter)
45 Northeast Industrial Road, Branford, CT 06405; (203) 488-8201
(Address, including zip code, and telephone
number, including area code, of registrants principal executive offices)
Common Stock, $0.025 par value per share
(Title of each class of securities covered by this Form)
n/a
(Titles of all other classes of securities for
which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
x
|
Rule 12g-4(a)(2)
|
|
¨
|
Rule 12h-3(b)(1)(i)
|
|
x
|
Rule 12h-3(b)(1)(ii)
|
|
¨
|
Rule 15d-6
|
|
¨
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934 Neurogen Corporation has caused this certification/notice
to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
Date:
|
|
December 24, 2009
|
|
By:
|
|
/s/ John Higgins, President
|
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and
Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly
authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
|
|
|
SEC2069(02-08)
|
|
Persons who respond to the collection of information contained
in this form are not required to respond unless the form displays
a currently valid OMB
control number.
|
Neurogen (NASDAQ:NRGN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Neurogen (NASDAQ:NRGN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Neurogen (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More News Articles